Dm. Dirig et al., EFFECT OF COX-1 AND COX-2 INHIBITION ON INDUCTION AND MAINTENANCE OF CARRAGEENAN-EVOKED THERMAL HYPERALGESIA IN RATS, The Journal of pharmacology and experimental therapeutics, 285(3), 1998, pp. 1031-1038
Intrathecal administration of nonsteroidal anti-inflammatory drugs in
the rat blocks the thermal hyperalgesia induced by tissue injury, whic
h suggests a role for spinal cyclooxygenase (COX) products in this fac
ilitated state. Two isozymes of the COX enzyme have been reported, COX
-1 and COX-2, but the agents thus far examined are not isozyme selecti
ve. We examined the effects of intrathecally (i.t.) or systemically (i
.p.) administered S(+)-ibuprofen (a nonselective COX inhibitor) or nyl
]-3-tri-fluoromethyl-5-(4-fluorophenyl)pyrazole (SC58125; a COX-2 sele
ctive inhibitor) on carrageenan-induced thermal hyperalgesia (reduced
hindpaw-withdrawal latency). The following observations were made: 1)
Thermal hyperalgesia otherwise observed during the first 170 min was b
locked in a dose-dependent manner by S(+)-ibuprofen or SC58125 adminis
tered i.t. or i.p. before carrageenan treatment. 2) Intraperitoneal, b
ut not i.t., administration of either inhibitor after the establishmen
t of hyperalgesia (170 min after carrageenan injection) reversed therm
al hyperalgesia in a dose-dependent manner. Thus, the initial componen
t of thermal hyperalgesia after tissue injury was blocked by systemic
or spinal administration of both COX inhibitors, whereas established h
yperalgesia was reversed only by systemic inhibitors. This study demon
strates that at least spinal COX-2, if not both COX-1 and COX-2, are n
ecessary for the initiation of thermal hyperalgesia, whereas nonspinal
sources of prostanoids (synthesized by COX-2 and perhaps also COX-1)
are important for the maintenance of thermal hyperalgesia associated w
ith tissue injury and inflammation.